CMS Introduces 80 New ICD-10-PCS Codes: What Providers and Coders Need to Know for FY 2026
From gene therapy breakthroughs to DRG-shifting non-OR procedures, CMS’s latest 80 PCS codes signal a major shift in coding and reimbursement.The Centers for Medicare & Medicaid Services (CMS) has released 80 new ICD-10-PCS procedure codes, bringing notable updates that will directly influence inpatient coding accuracy, MS-DRG assignment, and ultimately reimbursement outcomes.
These updates—effective for discharges through September 30, 2026—reflect ongoing advancements in gene therapy, wound care innovation, and minimally invasive procedural techniques. For healthcare organizations, this is more than a routine coding update—it’s a signal of where clinical practice and reimbursement models are heading.
Breaking Down the 80 New PCS Codes
CMS has categorized the new codes as follows:
- 24 OR (Operating Room) procedures
- 56 Non-OR procedures
- Of these, 27 impact MS-DRG assignment
This distinction is critical. While OR procedures typically drive DRG assignment directly, non-OR procedures that influence DRGs can significantly affect reimbursement if overlooked or miscoded.
Spotlight on Innovation: New Technology Codes
Among the most impactful additions are the New Technology Section (X codes)—often the most closely watched updates due to their connection to cutting-edge treatments.
Example: Gene Therapy for Congenital Deafness
One standout code is:
- XW0E33B – Introduction of DB-OTO via intracochlear infusion into ear(s), percutaneous approach, New Technology Group 11
This code represents a breakthrough therapy involving DB-OTO, a dual adeno-associated virus-based gene therapy designed to treat congenital deafness caused by otoferlin deficiency.
Otoferlin plays a critical role in synaptic transmission within cochlear hair cells, and its absence leads to profound hearing impairment. Historically, treatment options have been limited, with cochlear implants serving as the primary intervention.
However, findings published in the The New England Journal of Medicine (October 2025) demonstrated promising outcomes:
- 6 out of 12 patients regained the ability to hear soft speech without assistive devices
- 3 patients achieved near-normal hearing sensitivity
This represents a major shift toward curative, gene-based therapies, with long-term implications for both clinical practice and coding frameworks.
Lifecycle of New Technology (X) Codes
CMS continues to evaluate how emerging technologies should be integrated into ICD-10-PCS. Traditionally, new technology codes remain active for up to three years, after which CMS may take one of four approaches:
- Retain the code if the technology remains distinct
- Integrate the technology into existing PCS codes (e.g., adding qualifiers)
- Delete the code entirely if the technology becomes obsolete
- Create a new permanent code that fully incorporates the technology
For coding teams, this means ongoing vigilance is essential, especially when tracking technologies transitioning out of the X section.
Key Non–New Technology Additions
1. Wound Management Codes (18 New Codes)
CMS has introduced 18 new codes focused on wound care involving the:
- Musculoskeletal system
- Integumentary system (thorax and abdomen)
These codes capture advanced treatment modalities such as:
- Negative pressure wound therapy (NPWT)
- Orthotic and prosthetic applications
- Electrotherapeutic interventions
Important note:
These are classified as non-OR procedures, but many do impact MS-DRG assignment, making accurate documentation and coding essential for appropriate reimbursement.
2. Endoscopic Drainage Procedures (20 New Codes)
Another significant update includes 20 new endoscopic drainage codes targeting:
- Digestive system
- Biliary system
Key characteristics:
- All procedures involve drainage devices
- Qualifiers specify approach:
- Transmural
- Transpapillary
- Typically performed by interventional radiology or GI specialists
- Classified as non-OR procedures
These codes reflect the increasing adoption of minimally invasive drainage techniques, which require precise documentation of:
- Access route
- Device used
- Anatomical site
High-Impact New & Revised Codes (Selected Highlights)
While CMS released 80 codes, here are some of the most operationally relevant categories and examples your team should prioritize:
New Technology (Section X)
- XW0E33B – DB-OTO gene therapy (intracochlear infusion)
- Additional X codes related to:
- Targeted drug delivery systems
- Advanced biologics administration
- Device-assisted infusion technologies
Wound Care & Therapeutic Devices
New codes capturing:
- Negative pressure wound therapy (thoracic/abdominal sites)
- External orthotic/prosthetic device applications
- Electrical stimulation therapies
Gastrointestinal & Biliary Drainage
New endoscopic drainage codes including:
- Transmural drainage of pancreatic collections
- Transpapillary biliary drainage procedures
- Device-specific drainage interventions
DRG-Sensitive Non-OR Procedures
27 newly introduced codes that:
- Do not require an operating room
- Still influence MS-DRG grouping, impacting reimbursement
Why These Updates Matter for Your Practice
These changes are not just administrative—they directly affect:
1. Reimbursement Accuracy
Missing a DRG-impacting non-OR code could result in underpayment or claim denials.
2. Clinical Documentation Integrity (CDI)
Providers must clearly document:
- Procedure approach
- Devices used
- Anatomical specificity
- Technology type (especially for X codes)
3. Coding Team Readiness
Your coding staff should:
- Review all new codes in detail
- Update internal coding guidelines
- Align with CDI teams to ensure documentation supports specificity
4. Strategic Positioning for Emerging Therapies
With innovations like gene therapy entering mainstream coding systems, organizations must be prepared to:
- Capture high-value procedures accurately
- Justify medical necessity
- Align with payer expectations
Final Thoughts
The addition of these 80 ICD-10-PCS codes underscores a broader trend: coding systems are rapidly evolving to keep pace with clinical innovation.
From gene therapy breakthroughs to advanced wound care and minimally invasive drainage procedures, these updates demand a proactive, detail-oriented approach from both providers and revenue cycle teams.
Now is the time to:
- Educate your staff
- Audit your documentation workflows
- Ensure your coding processes are aligned with FY 2026 updates
Because in today’s environment, precision in coding is no longer optional—it’s a financial and operational imperative.
Turning Coding Complexity into Financial Opportunity
The latest ICD-10-PCS updates from the Centers for Medicare & Medicaid Services are a clear reminder that medical coding is no longer just a back-office function—it’s a strategic driver of revenue integrity.
With the introduction of 80 new procedure codes, including DRG-impacting non-OR services and highly specialized new technology procedures, even small gaps in documentation or coding accuracy can lead to:
- Missed reimbursement opportunities
- Increased claim denials
- Compliance risks and audit exposure
For many organizations, keeping pace with these changes—while maintaining productivity and accuracy—is becoming increasingly difficult.
That’s where a specialized partner can make a measurable difference.
At Bristol Healthcare Services, we help practices and healthcare organizations stay ahead of evolving coding requirements through:
- Certified, specialty-specific coding expertise across 40+ disciplines
- Real-time updates aligned with CMS changes and payer guidelines
- Proactive coding audits and documentation improvement strategies
- Advanced technology and automation to reduce errors and accelerate turnaround times
Our approach goes beyond basic code assignment—we focus on capturing the full clinical picture, ensuring that every procedure performed is accurately translated into optimal reimbursement.
As coding complexity continues to grow—especially with emerging technologies like gene therapy and minimally invasive interventions—partnering with the right experts can be the difference between revenue leakage and revenue optimization.
Schedule a free consultation today – no commitment required.